Commercial TLL Insights

The TLL Catalyst Platform

Your Thought Leader Interactions Generate Strategic Value. Now Convert It into Decisive Commercial Advantage.

The TLL Catalyst platform is built for Thought Leader Liaisons and commercial leadership seeking to turn KOL interactions into strategic advantage. It connects high-value expert dialogue directly to brand strategy, launch readiness, and competitive market share.

Instead of letting critical signals slip into static slides or inbox chains, teams capture the real-world intelligence needed to refine positioning, remove adoption bottlenecks, and build commercial momentum.

Operating seamlessly alongside your existing CRM, KOL databases, and Microsoft environment, TLL Catalyst delivers commercial impact from day one.

Protect Critical Intelligence: Reduce fragmented collation and help turn qualitative KOL feedback into timely commercial direction.

Drive Commercial Development: Support TLLs in moving beyond routine data collection to help shape brand planning and address treatment friction.

De-Risk Launches and Drive Adoption: Surface potential adoption bottlenecks, institutional hurdles, and shifting prescriber beliefs before they impact brand performance.

See the Broader Context: Recognise when qualitative feedback from an isolated conversation reflects an emerging pattern across wider accounts or territories.

Understand Changing Perspectives: Track what key experts express, calibrate against observed real-world behaviours, and evaluate how both shift over time.

Make Follow-Through Visible: Link findings directly to executive decisions and tactical actions, ensuring critical feedback is owned, tracked, and resolved.

THE OPPORTUNITY

Elevating Expert Engagements into Decisive Commercial Direction

Your team hears valuable feedback, but today’s TLL insights workflow can be constrained by fragmented tools. While teams uncover pivotal commercial signals across key account interactions, that intelligence can easily disappear into slides, spreadsheets, personal inboxes, and unstructured CRM call notes.

A concern raised in one account may be quietly developing elsewhere. An expert’s perspective may have shifted since the last advisory board. A strategic question escalated to leadership can easily sit unanswered in an email chain.

When key account observations remain trapped in silos, commercial development and brand agility can stall. Manual collation often becomes an operational bottleneck – delaying brand adjustments, slowing response times, and leaving competitive positioning vulnerable in contested categories.

01 Critical Intelligence Lost in Silos

Valuable observations on competitor data, brand resonance, institutional hurdles, and diagnostic delays often remain confined to individual territory notes. This makes it difficult for commercial leadership to adjust strategy and defend market share in real time. Bringing these scattered observations together into one central environment helps clarify whether an issue is an isolated event, a recurring theme, or a widespread commercial risk.

02 Translating Account Dialogue into Market Impact

Commercial teams need to move quickly, yet translating nuanced KOL insights into brand strategy often remains a slow, manual process. Teams frequently spend valuable hours on repetitive data entry, administrative collation, and slide preparation instead of focusing on strategic execution, trend analysis, and deciding how best to respond.

03 Closing the Accountability Gap

Capturing an observation is only the first step. When gathered intelligence lacks structured routing, clear ownership, and systematic follow-through, critical signals can fail to reach the Brand Directors, Market Access partners, and Commercial Executives who steer brand development. Without clear accountability, an essential finding often stops at the slide deck – leaving teams unsure whether their insights informed the wider plan.

WHAT THE TLL CATALYST PLATFORM OFFERS

One Unified Foundation for Commercial Strategy & Account Intelligence

The TLL Catalyst platform bridges the gap between frontline reality and commercial vision. It provides one place to understand stakeholder feedback and act on it, transforming qualitative expert interactions into structured commercial direction and connecting team insights directly with decision-makers.

Drive Commercial Strategy and Development: Keep your brand roadmap, target product profile, and commercial messaging continuously informed by real-world expert feedback to support uptake and brand performance.

Reduce Strategy-to-Execution Cycle Times: Move from insight to commercial action with greater speed, categorising, prioritising, and translating qualitative observations into concrete tactics.

De-Risk Launches and Inform Market Penetration: Support launch readiness by using real-time thought leader feedback on clinical gaps, treatment paradigms, and competitor developments to guide pre-launch planning.

Unify Multi-Channel Intelligence: Ingest qualitative 1:1 notes, account discussions, advisory board themes, and leadership briefings via a mobile-first capture layer that fits existing routines and cleans data automatically.

Embed Practical AI at Every Stage: Leverage specialised intelligence models to draft pre-meeting briefings, structure informal notes, detect early signals, and author executive summaries while keeping human oversight in control.

Unite Cross-Functional Teams: Reduce internal silos by connecting Commercial, Market Access, and Brand teams around shared, verified intelligence to coordinate effectively on access barriers and brand positioning.

Connect Findings to Direct Follow-Up: Route strategic issues to appropriate commercial owners, assign concrete next steps, and automatically notify TLLs when their insights inform strategic adjustments.

Find Patterns Across Accounts: Synthesise observations across territories to identify recurring clinical themes, regional sentiment variances, and shifts in clinician mindsets following new trial readouts or competitor moves.

Precision Resource Allocation: Segment KOLs across multiple dimensions to deploy operational resources, educational programmes, and budgets where they can have the greatest impact.

Stay Compliant by Design: Maintain strict boundaries between commercial observations and scientific exchange, distinguishing direct observations from user inferences with role-based controls and complete auditability.

STRATEGY

Everything Linked to Commercial Strategy & Market Needs

In the TLL Catalyst platform, driving commercial strategy and brand development lies at the heart of everything. Organising observations is useful, but answering the questions behind your commercial plans and understanding what feedback means for your strategic priorities makes it invaluable.

A. Strategy Integrated

The TLL Catalyst platform integrates your strategy directly into its analytical engine. Dedicated inputs accommodate brand imperatives, strategic objectives, launch roadmaps, and Key Business Questions (KBQs) – establishing a consistent framework to evaluate, filter, and contextualise incoming observations while aligning pre-meeting briefings with key priorities:

How do corporate brand imperatives and launch milestones translate into everyday account objectives?
Which specific Key Business Questions (KBQs) should guide each upcoming thought leader interaction?
How can pre-meeting briefing dossiers automatically reflect the latest strategic priorities of the brand?
What criteria ensure incoming qualitative feedback is tagged directly to commercial pillars rather than lost in generic notes?
How do cross-functional priorities across Market Access and Brand Marketing align within the TLL engagement plan?

B. Strategy Validated and Informed

Because the TLL Catalyst platform reflects your strategic imperatives, it actively tests intelligence gathered against prevailing commercial assumptions:

Which conversations and insights reinforce current positioning and messaging against competitors?
Which critical questions regarding clinical evidence or trial readouts remain unresolved in the medical community?
Where does clinician feedback suggest a potential need to refine launch strategy or reallocate commercial resources?
Are institution-level treatment protocols and pathways developing in ways that support projected adoption and overall market position?
How are top thought leaders and key accounts responding to recent competitor developments, pipeline updates, and label expansions?

C. Strategy Created and Developed

The TLL Catalyst platform pairs analytical rigour with embedded AI to help guide commercial development by interrogating practical opportunities and threats around your existing plans:

What emerging competitor insights could challenge your category share if left unaddressed?
Which real-world operational bottlenecks might require new commercial support programmes to clear pathways for adoption?
What new educational or access initiatives should be considered ahead of the next brand planning cycle to strengthen long-term positioning?
Where do frontline observations suggest a need to revisit baseline assumptions before committing additional spend?
Which unexpected regional treatment trends present immediate opportunities to expand market penetration?

THE CONSOLE

The Workspace Built Around the Commercial Jobs You Need to Get Done

The workspace is structured around the actual tasks TLLs and Commercial Leadership navigate daily. Delivering organised observations, transforming account dialogue into intelligence, and generating summaries is helpful, but true value lies in enabling teams to complete critical work with low friction. Start with the task at hand to achieve your commercial and competitive goals.

This Is Where Commercial Strategy Gets Built:

Job To Be Done	Platform Functional Capability
Prepare for an Engagement	Pull historical account context, past sentiment trajectories, open stakeholder questions, and agreed outstanding commitments in seconds before stepping into a key meeting.
Surface Emerging Market Shifts	Identify subtle signals, regional variances, and pattern changes across accounts via interactive dashboards before they appear in lagging market-share metrics.
Prepare Strategic Account Briefs	Instantly compile balanced, strategic 1:1 briefing packs ahead of critical commercial engagements and executive leadership discussions.
Investigate a Commercial Question	Query months of multi-territory qualitative feedback in plain English and receive instant answers referencing verified underlying account observations.
Triangulate Competitor Moves	Aggregate how community versus academic clinicians are reacting to competitor trial readouts, label updates, or pricing models to adjust commercial positioning proactively.
Understand Stakeholder Positions	Review multi-dimensional sentiment and advocacy trajectories by specific clinical topic, backed by direct observation histories.
Coordinate Cross-Functional Action	Link findings directly to assigned next steps across Market Access, Brand Marketing, and Patient Services, tracking progress against clear owners.
Brief Executive Leadership	Rapidly generate objective brand summaries, emerging market threat assessments, supporting evidentiary quotes, and status updates on key actions.

EMBEDDED AI ADVANTAGE

Practical AI Designed for Life Sciences Realities

The TLL Catalyst platform integrates specialised AI models not to replace human strategic judgment, but to eliminate administrative friction, amplify analytical speed, and distil large volumes of qualitative text into structured business intelligence. Spend less time processing information and more time driving strategy.

At Ingestion (AI-Assisted Structuring): Cleans informal notes, standardises medical terminology, tags topics against brand imperatives, standardises unstructured entries, and flags sensitive or out-of-scope terms for proper handling.

During Synthesis (Pattern and Signal Detection): Scans qualitative inputs across accounts to help isolate early market shifts, clinical contradictions, regional perception discrepancies, and emerging barriers that manual reviews miss.

In Reporting (Automated Narrative Generation): Converts notes, advisory board findings, and account observations into drafted executive summaries, trend briefs, and commercial impact narratives in seconds for teams to refine and distribute.

In Exploration (Conversational Querying): Enables commercial directors and brand leads to ask complex business questions in plain English and receive clear, referenced summaries drawn directly from underlying, verified evidence.

Responsible AI and Governance Standard: AI-generated outputs serve as analytical accelerators, not final decisions. Internal teams review AI drafts, examine underlying referenced source evidence, and retain full responsibility for interpretation, commercial actions, and strategic decision-making.

SENTIMENT & ADVOCACY MANAGEMENT

Move Beyond Binary Checkboxes: Measure What Experts Think vs. What They Do

A positive opinion does not always tell the whole story. In commercial development, clinical enthusiasm does not necessarily translate directly into clinical practice, guideline endorsement, or brand adoption. An expert may be genuinely enthusiastic about Phase III efficacy data, yet remain hesitant when institutional protocols, formulary reviews, administration logistics, or patient out-of-pocket costs come into play. A single overall rating can easily obscure those distinctions.

1. Decoupling Perspectives from Observed Behaviours

Topic-Level Sentiment (The Mindset): Captures what an expert expresses regarding a specific therapy, dataset, clinical guideline, or unmet need, evaluated along an objective, consistent spectrum.

Active Advocacy (The Mobilisation): Measures the tangible, observed extent to which the expert actively supports, recommends, educates, speaks on podiums, or drives pathway adoption within their institution.

Evidentiary Rigour and Uncertainty: Raw observations and observed actions are separated from internal team interpretations, allowing to record uncertainty rather than relying on guesswork.

2. Evaluating Nuance at the Topic Level

Experts rarely have a single, blanket opinion across all commercial aspects of a brand. The platform maps sentiment and advocacy using an agreed multi-axial framework across customized commercial topics:

An expert may display favourable sentiment and high advocacy for your compound’s novel mechanism of action or primary efficacy data
Yet that same expert may display considerable concern and zero advocacy regarding nursing support requirements or specialised co-pay support.
Decoupling these topics provides commercial and market access teams with a clear, specific basis for targeted follow-up.

3. Tracking Longitudinal Trajectories

Perceptions and clinical practices evolve over time. The TLL Catalyst platform models movement over time:

Track how sentiment and advocacy migrate before and after major competitor data releases, guideline changes, or regulatory milestones.
Surface quiet supporters (favourable sentiment, low advocacy) ready to be activated into regional peer-to-peer education, speaker programmes, or advisory initiatives.
Note early-warning signals when a previously supportive influencer shifts following newly published real-world evidence, giving brand teams the opportunity to respond proactively.

THE STRATEGIC FLYWHEEL

Turn Signals into Action: Measure, Target, Engage, Learn

Capturing expert interactions is most valuable when it drives coordinated commercial behaviour. The TLL Catalyst platform operationalises a closed-loop engine that translates qualitative dialogue into targeted execution, using each round of feedback to systematically inform the next.

01 MEASURE

Multi-Lens Advocacy

02 TARGET

Precision Segmentation

03 ENGAGE

N=1 Tailored Execution

04 REVIEW

Closed-Loop Validation

Informs Next Cycle & Learning

1. MEASURE: Multi-Lens Advocacy and Sentiment

When integrated with your ecosystem, the platform can continuously benchmarks thought leaders across multiple strategic lenses:

Sentiment (Internal View): Score stakeholder sentiment across distinct commercial topics (such as efficacy, safety, dosing, and access) during 1:1 interactions and congress touchpoints.

Declared Mindset (External Voice): Calibrate internal observations against direct surveys, advisory board findings, and structured pulse checks to benchmark alignment with your brand story.

Scientific Messaging and Podium Behaviour: Objectively track what KOLs say in public outputs for your brand and competitors.

Collaboration Preferences: Systematically capture preferred interaction channels, clinical interests, and appetite for collaborative commercial initiatives.

2. TARGET: Precision Segmentation and Prioritisation

Rather than treating KOL tiers uniformly, the platform segments stakeholders at an individual level based on live evidence:

Isolate Perception and Knowledge Gaps: Identify clinician cohorts with lower message resonance or unresolved questions, such as lingering concerns over safety following a competitor readout.

Prioritise High-Leverage Targets: Shift commercial focus away from saturated champions toward clinicians who favour your therapy but require institutional operational support to become active prescribers.

Dynamically Adapt to Market Events: Rapidly re-segment target KOL networks following label updates, new competitor data readouts, or clinical guideline revisions.

3. ENGAGE: Tailored Account Execution

Equip TLLs and Brand Directors with focused, relevant interaction plans rather than generic account decks, answering:

Which KOL relationships need closer attention?
Which KOLs are currently well engaged and require less frequent direct contact?
What specific data points, topics, or access answers does each KOL need next?

Strategic Pre-Meeting Briefs: Pull past sentiment trajectories, unresolved questions, institutional hurdles, and past commitments before walking into key accounts.

Channel and Content Alignment: Help deliver resources matched precisely to stakeholder preferences

4. REVIEW, RE-MEASURE AND LEARN: Closed-Loop Verification

Close the strategic loop by recording subsequent interactions, observed behavioural shifts, and account outcomes:

Track Perception Shifts: Assess how targeted engagements move sentiment and advocacy metrics over time, confirming the direct impact of commercial strategy.

Assess External Influences: Evaluate changes in stakeholder behaviour alongside wider market developments, competitive entries, or formulary decisions.

Continuous Brand Learning: Feed validated outcomes back into corporate Key Business Questions, brand roadmaps, and messaging for subsequent cycles.

VALUE FOR KEY TEAMS

Commercial and Brand Leadership

Drive Commercial Agility: Turn raw insights into actionable brand strategy rapidly, accelerating campaign adjustments, messaging refinement, and launch readiness.

Understand What Warrants Attention: Better distinguish between isolated territory noise and critical market issues that demand immediate strategic intervention.

Support Long-Term Market Performance: Identify and eliminate operational and clinical barriers early, providing the strategic clarity needed to protect market share.

Support Decision Traceability: Trace account insights directly through to recorded corporate actions, marketing adjustments, and board-level resource decisions.

Optimise Commercial Resource Allocation: Deploy your team with precision – directing budget and account support where they create demonstrable commercial uplift.

Thought Leader Liaisons (TLLs)

From Data Collectors to Strategic Drivers: Move beyond administrative reporting to deliver high-impact intelligence that directly shapes corporate commercial roadmaps.

Carry Context into Every Discussion: Access comprehensive account histories, historical sentiment shifts, unanswered questions, and agreed commitments instantly before stepping into an account.

High-Level Discussion Dossiers: Rapidly assemble balanced, strategic briefing summaries ahead of key commercial leadership visits.

Closed-Loop Visibility and Follow-Through: Receive clear system notifications showing exactly which Brand, Market Access, or Clinical leads reviewed your account intelligence and what decisions resulted from it.

Market Access and Operations Teams

Uncover Real-World Access Hurdles Early: Identify formulary delays, reimbursement pushback, operational site burden, and diagnostic bottlenecks before they restrict patient access.

Corroborate Account Signals Across Regions: Compare reported challenges across institutions to determine whether an access hurdle requires localised account support or a national programmatic response.

Coordinate with Clear Ownership: Eliminate cross-functional friction by working from assigned action items, shared tracking records, and governed intelligence.

Stop Letting KOL Insights Disappear. Start Driving Commercial Momentum.

Discover how the TLL Catalyst platform connects individual account observations with overarching market patterns, granular stakeholder perspectives, and decisive corporate follow-up. See what your stakeholder feedback could tell you, from meeting preparation through to analysis and follow-up.

Empower your commercial organisation with a connected, real-time view of what thought leaders think – and see exactly what needs to happen next.